All Articles

NexPoint thrives amid credit market turmoil by pairing cycle-resistant assets with a high-yield lending offensive, revealing a durable model for value creation.

While others chase scale, Netgain proves that deep expertise in regulated sectors like healthcare and legal is the key to sustained growth and industry leadership.

As AI adoption outpaces governance, a new firm is creating a credit score-like system for AI risk. With a high-powered advisory board, is this the key to resilience?

MacPaw's Moonlock didn't just win; it swept the Stevie Awards. This triple victory for its team, talent, and tech reveals a deeper strategy for Mac users.

A "Product of the Year" award for a dog treat is more than just news. It reveals a deep shift in corporate strategy and the growing pet wellness system.

With the launch of its TED drug Lumvoa, Viridian Therapeutics steps into the commercial ring. But can early momentum and a deep pipeline justify the cost?

The Edinburgh International Festival bets big on America's 250th, leveraging cultural diplomacy and star power for a major economic and reputational payoff.

A controversial drug program is the unlikely financial engine keeping rural hospitals afloat. Inside Phoebe Putney's model for reinvesting savings.

A new government initiative is accelerating a massive Québec phosphate mine, revealing a strategy to secure vital resources for food and batteries.

With a return to profitability and digital revenue soaring, Lee Enterprises' Q3 results reveal a potent mix of financial strategy and digital transformation.

A new federal grant is helping Frontier Lithium turn mining by-products into valuable fertilizer, a key step in building a greener North American battery supply chain.

With nearly $800M in cash, Immunovant is all-in on a single drug, IMVT-1402. Can its ambitious six-front clinical strategy justify the burn and win the race?

Gogo's Q2 results show a net loss, but a 40% surge in military revenue is funding its critical, costly transition to next-gen Galileo and 5G services.

With its acquisition of Global Ledger and the hire of Novo's co-founder, OpenFX is building a bank for the fintechs that traditional finance won't touch.

Fox Corp. posts record earnings fueled by the World Cup, but the real story is its massive $22B bet on Roku to conquer the future of television streaming.

Priovant's Phase 3 trial for brepocitinib in cutaneous sarcoidosis isn't just about one disease. It's a key move in Roivant's playbook to build a rare disease powerhouse.

The Yankees partner with prediction market Polymarket, signaling a major shift in sports sponsorship, fan engagement, and regulated financial technology.

The utility's strong Q2 results are fueled by massive energy demand from new data centers, prompting a $1B capital plan increase and promising regional growth.

American Growth Insurance's acquisition of Heller-Kowitz isn't just another deal. It’s the first move in a high-stakes bet to rebuild Main Street agencies.

A strategic hire at RegTech firm RiskExec reveals a new reality: AI is no longer just a tool, but a core strategy for navigating financial regulation.